by Lauren Limbach | Oct 20, 2020 | Biostabilizer, LBP, Physical Therapy / Medicine and Rehabilitation
In recent years there have been growing concerns over the prevalence of lower back pain (LBP) in children. Of particular concern to parents, teachers and medical professionals are the overloaded backpacks and excessive screen time habits that may play a role in the... by Lauren Limbach | Oct 16, 2020 | Biostabilizer, LBP, Physical Therapy / Medicine and Rehabilitation
by Vicky Lu and Lauren Limbach The opioid epidemic is a large burden on the American healthcare system. In 2015, opioid overdoses were responsible for over 140,000 emergency department visits and estimated to cost $152.8 million for the medical industry (1). By 2016,... by Felicia Schuessler | Sep 15, 2020 | Athletic, Biostabilizer, Issues, LBP, Physical Therapy / Medicine and Rehabilitation, Solutions
For 80% of people, an episode of low back pain (LBP) occurs at least once during the lifespan,(4) and about 38% of people have an episode once a year.(2) However, certain populations experience LBP differently. LBP in athletes is a serious condition related both to... by Lauren Limbach | Sep 14, 2020 | Biostabilizer, LBP, Medical Officers, Physical Therapy / Medicine and Rehabilitation
Lower back pain (LBP) and depression are both personally and financially devastating conditions that have severe consequences for an individual’s quality of life. Currently, LBP is the leading global cause of disability, however, rising levels of depression around the... by Radhika Shah | Sep 10, 2020 | Biostabilizer, Physical Therapy / Medicine and Rehabilitation
In the United States, over seven million people are affected by scoliosis (1). This abnormal curvature of the spine is often diagnosed during childhood or early adolescence. Each year, an estimated 30,000 children are put in spinal braces and about 38,000 patients go... by Felicia Schuessler | Sep 9, 2020 | Biostabilizer, Issues, Medical Officers, Physical Therapy / Medicine and Rehabilitation, Solutions
Musculoskeletal (MSK) conditions affect 25% of people worldwide, and they cost the western world billions of dollars in GDP through loss of productivity and healthcare expenditures.(2) With the high prevalence and extensive costs of these conditions, maximizing access... 